Cooper Companies (NASDAQ:COO) Given Hold Rating at Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Cooper Companies (NASDAQ:COO) in a report released on Friday morning,Benzinga reports.

A number of other equities analysts have also recently issued reports on COO. Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company lifted their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Morgan Stanley cut their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average price target of $111.89.

Cooper Companies Stock Down 6.6 %

NASDAQ COO opened at $85.00 on Friday. The stock has a market capitalization of $16.96 billion, a P/E ratio of 43.59, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. Cooper Companies has a 52 week low of $82.61 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a fifty day moving average of $92.52 and a 200-day moving average of $99.45.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. On average, equities research analysts forecast that Cooper Companies will post 3.98 EPS for the current year.

Institutional Investors Weigh In On Cooper Companies

Several large investors have recently modified their holdings of the business. Ashton Thomas Securities LLC acquired a new stake in Cooper Companies during the 3rd quarter worth approximately $25,000. Byrne Asset Management LLC bought a new stake in shares of Cooper Companies during the fourth quarter worth $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies during the fourth quarter worth $34,000. Covestor Ltd lifted its position in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares in the last quarter. Finally, New Age Alpha Advisors LLC acquired a new position in Cooper Companies in the 4th quarter worth $38,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.